The effect of rituximab on the quality of life of children with refractory nephrotic syndrome-Reference-Cited by-同舟云学术

The effect of rituximab on the quality of life of children with refractory nephrotic syndrome

Published:2021-12-02 Issue:1 Volume:64 Page:
ISSN:1328-8067
Container-title:Pediatrics International
language:en
Short-container-title:Pediatrics International

Author:

Takahashi Toshiyuki¹^ORCID,Okamoto Takayuki¹^ORCID,Yokota Isao²,Sato Yasuyuki¹,Hayashi Asako¹,Ueda Yasuhiro¹,Aoyagi Hayato³,Ueno Michihiko⁴,Kobayashi Norio⁵,Uetake Kimiaki⁶,Nakanishi Masanori⁷,Ariga Tadashi¹

Affiliation:

1. Department of Pediatrics Hokkaido University Graduate School of Medicine Sapporo Japan

2. Department of Biostatistics Hokkaido University Graduate School of Medicine Sapporo Japan

3. Department of Pediatrics Obihiro Kyokai Hospital Obihiro Japan

4. Department of Pediatrics Nikko Memorial Hospital Muroran Japan

5. Department of Pediatrics Oji General Hospital Tomakomai Japan

6. Department of Pediatrics Obihiro Kosei Hospital Obihiro Japan

7. Department of Pediatrics Kushiro Red Cross Hospital Kushiro Japan

Publisher

Wiley

Subject

Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ped.14725

Reference20 articles.

1. High incidence of idiopathic nephrotic syndrome in East Asian children: a nationwide survey in Japan (JP-SHINE study)

2. Rituximab for nephrotic syndrome in children

3. Morbidity in children with frequently relapsing nephrosis: 10-year follow-up of a randomized controlled trial

4. PedsQL™ 4.0: Reliability and Validity of the Pediatric Quality of Life Inventory™ Version 4.0 Generic Core Scales in Healthy and Patient Populations

5. Impaired health-related quality of life in children and adolescents with chronic conditions: a comparative analysis of 10 disease clusters and 33 disease categories/severities utilizing the PedsQL™ 4.0 Generic Core Scales

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Changes in bone turnover markers after discontinuing long-term glucocorticoid administration in children with idiopathic nephrotic syndrome: a multicenter retrospective observational study;Pediatric Nephrology;2023-04-13

2. Comparison of rituximab, cyclophosphamide, and tacrolimus as first steroid-sparing agents for complicated relapsing/steroid-dependent nephrotic syndrome in children: an evaluation of the health-related quality of life;Archives of Medical Science;2022-01-17